扶桑薬品工業(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4538/E00953Fuso Pharmaceutical Industries, Ltd.
公表日公表担保貸付残高前週比借入残高(自己)前週比借入残高(転貸)前週比
2025/02/07日証協無担保0株0%0株0%58,983株+1.2%
2025/02/07日証協有担保70,024株+42.84%119,521株+127.72%76,500株+87.5%
2025/01/31日証協無担保0株-100%0株0%58,283株-49.68%
2025/01/31日証協有担保49,024株+15.29%52,486株+3.75%40,800株+22.89%
2025/01/24日証協無担保57,300株0%0株0%115,821株+2.03%
2025/01/24日証協有担保42,524株+6.22%50,590株+62.67%33,200株+1.84%
2025/01/17日証協無担保57,300株0%0株0%113,521株0%
2025/01/17日証協有担保40,034株-6.77%31,100株+37.06%32,600株+4.15%
2025/01/10日証協無担保57,300株0%0株0%113,521株+3.75%
2025/01/10日証協有担保42,940株-4.16%22,691株+26.6%31,300株+44.24%
2024/12/30日証協無担保57,300株0%0株0%109,421株-0.09%
2024/12/30日証協有担保44,804株+0.67%17,923株+7.83%21,700株0%
2024/12/27日証協無担保57,300株0%0株0%109,521株-2.06%
2024/12/27日証協有担保44,504株-3.75%16,621株-6.16%21,700株+1.12%
2024/12/20日証協無担保57,300株-16.96%0株0%111,821株0%
2024/12/20日証協有担保46,236株-15.19%17,713株-10.09%21,460株-10.95%
2024/12/13日証協無担保69,000株0%0株0%111,816株+1.72%
2024/12/13日証協有担保54,517株-10.72%19,700株-2.96%24,100株-16.03%
2024/12/06日証協無担保69,000株0%0株0%109,921株0%
2024/12/06日証協有担保61,064株+3.04%20,300株-4.69%28,700株+8.3%
2024/11/29日証協無担保69,000株0%0株0%109,921株-0.81%
2024/11/29日証協有担保59,264株-8.56%21,300株-0.93%26,500株-16.67%
2024/11/22日証協無担保69,000株0%0株0%110,821株-0.06%
2024/11/22日証協有担保64,815株+1.89%21,500株+2.38%31,800株+2.25%
2024/11/15日証協無担保69,000株0%0株0%110,883株+0.18%
2024/11/15日証協有担保63,615株+21.65%21,000株+3.45%31,100株-3.12%
2024/11/08日証協無担保69,000株0%0株0%110,683株-11.44%
2024/11/08日証協有担保52,292株-23.56%20,300株-0.98%32,100株-9.07%
2024/11/01日証協無担保69,000株0%0株0%124,983株-0.95%
2024/11/01日証協有担保68,413株+55.23%20,500株-3.76%35,300株+98.31%
2024/10/25日証協無担保69,000株0%0株0%126,183株-0.47%
2024/10/25日証協有担保44,073株-26.76%21,300株-32.81%17,800株+4.09%
2024/10/18日証協無担保69,000株-0.14%0株0%126,783株-0.16%
2024/10/18日証協有担保60,173株-3.06%31,700株-3.65%17,100株-0.58%
2024/10/11日証協無担保69,100株+0.14%0株0%126,983株-0.16%
2024/10/11日証協有担保62,073株+49.57%32,900株-1.79%17,200株+0.58%
2024/10/04日証協無担保69,000株-1.43%0株0%127,183株+5.92%
2024/10/04日証協有担保41,501株+100.87%33,500株+51.58%17,100株-29.92%

※株式分割は考慮していませんのでご注意ください。

Page Top